The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Adjuvant Therapy for completely resected Stage II Colon Cancer
Open accessAbstract
BACKGROUND: Colon cancer is potentially curable by surgery. Although adjuvant chemotherapy benefits patients with stage III disease, there is uncertainty of such benefit in stage II colon cancer. A systematic review of the literature was performed to better define the potential benefits of adjuvant therapy for patients with stage II colon cancer. OBJECTIVES: To determine the effects of adjuvant therapy on overall survival and disease-free survival in patients with stage II colon cancer. SEARCH STRATEGY: Ovid MEDLINE (1986-2007), EMBASE (1980-2007), and EBM Reviews - Cochrane Central Register of Controlled Trials ( to 2007) were searched using the medical headings "colonic neoplasms", "colorectal neoplasms", "adjuvant chemotherapy", "adjuvant radiotherapy" and "immunotherapy", and the text words "colon cancer" and "colonic neoplasms". In addition, proceedings from the annual meetings of the American Society of Clinical Oncology and the European Society of Medical Oncology (1996 to 2004) as well as personal files were searched for additional information. SELECTION CRITERIA: Randomized trials or meta-analyses containing data on stage II colon cancer patients undergoing adjuvant therapy versus surgery alone. DATA COLLECTION AND ANALYSIS: :Three reviewers summarized the results of selected studies. The main outcomes of interest were overall and disease-free survival, however, data on toxicity and treatment delivery were also recorded. MAIN RESULTS: With regards to the effect of adjuvant therapy on stage II colon cancer, the pooled relative risk ratio for overall survival was 0.96 (95% confidence interval 0.88, 1.05). With regards to disease-free survival, the pooled relative risk ratio was 0.83 (95% confidence interval 0.75, 0.92). AUTHORS' CONCLUSIONS: Although there was no improvement in overall survival in the pooled analysis, we did find that disease-free survival in patients with stage II colon cancer was significantly better with the use of adjuvant therapy. It seems reasonable to discuss the benefits of adjuvant systemic chemotherapy with those stage II patients who have high risk features, including obstruction, perforation, inadequate lymph node sampling or T4 disease. The co-morbidities and likelihood of tolerating adjuvant systemic chemotherapy should be considered as well. There exists a need to further define which high-risk features in stage II colon cancer patients should be used to select patients for adjuvant therapy. Also, researchers must continue to search for other therapies which might be more effective, shorter in duration and less toxic than those available today.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Self-citationLe Voyer, T. E., Sigurdson, E. R., Hanlon, A. L., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.062 · Cited by 1,149
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
(1995) · The Lancet · doi:10.1016/s0140-6736(95)90696-7 · Cited by 1,066
Gill, S., Loprinzi, C. L., Sargent, D. J., Thomé, S. D., Alberts, S. R., Haller, D. G., Benedetti, J., Francini, G., Shepherd, L. E., Francois Seitz, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.059 · Cited by 1,021
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, C. J., Francini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6071 · Cited by 713
Laurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., & Malliard, J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1447 · Cited by 700
Riethmüller, G., Gruber, R., Schneider-Gädicke, E., Schlimok, G., Witte, J., Raab, R., Pichlmayr, R., Pichlmaier, H., Schmiegel, W., Buggisch, P., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92398-1 · Cited by 633
O'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.246 · Cited by 585
Jones, S. E., & Salmon, S. E. (1990) · Medical Entomology and Zoology · Cited by 532
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
Berger, A. C., Sigurdson, E. R., LeVoyer, T., Hanlon, A., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8852 · Cited by 518
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07186-4 · Cited by 504
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
(1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1356 · Cited by 444
Browman, G. P., Levine, M. N., Mohide, E. A., Hayward, R. S., Pritchard, K. I., Gafni, A., & Laupacis, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.502 · Cited by 440
Patterns of recurrence after curative resection of carcinoma of the colon and rectum.
Galandiuk, S., Wieand, H. S., Cg, M., Cha, S. S., Rj, F., Jh, P., & Wolff, B. G. (1992) · PubMed · Cited by 438
Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011
Wolmark, N., Fisher, B., Rockette, H., Redmond, C., Wickerham, D. L., Fisher, E. R., Jones, J., Glass, A., Lerner, H., Lawrence, W., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.30 · Cited by 400
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer
(1990) · JAMA · doi:10.1001/jama.264.11.1444 · Cited by 394
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
Halling, K. C., French, A. J., McDonnell, S. K., Burgart, L. J., Schaid, D. J., Peterson, B. J., Moon-Tasson, L., Mahoney, M. R., Sargent, D. J., O'Connell, M. J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1295 · Cited by 375
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., & Glick, J. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.12.2936 · Cited by 369
Genomic instability and colon cancer
Grady, W. M. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025861527711 · Cited by 353
Figueredo, A., Charette, M. L., Maroun, J., Brouwers, M. C., & Zuraw, L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.087 · Cited by 348
Self-citation(1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-1-141_2 · Cited by 332
Harris, J. E., Ryan, L., Hoover, H. C., Stuart, R. K., Oken, M. M., Benson, A. B., Mansour, E., Haller, D. G., Manola, J., & Hanna, M. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.148 · Cited by 273
Clinically useful measures of effect in binary analyses of randomized trials
Sinclair, J. C., & Bracken, M. B. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90191-0 · Cited by 270
Hoover, H. C., Brandhorst, J. S., Peters, L. C., Surdyke, M. G., Takeshita, Y., Madariaga, J., Muenz, L. R., & Hanna, M. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.390 · Cited by 259
Spitzer, W. O. (1986) · Journal of Chronic Diseases · doi:10.1016/0021-9681(86)90107-4 · Cited by 259
A Systematic Overview of Chemotherapy Effects in Colorectal Cancer
Ragnhammar, P., Hafström, L., Nygren, P., & Glimelius, B. (2001) · Acta Oncologica · doi:10.1080/02841860151116367 · Cited by 246
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
Francini, G., Petrioli, R., Lorenzini, L., Mancini, S., Armenio, S., Tanzini, G., Marsili, S., Aquino, A., Marzocca, G., Civitelli, S., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90748-x · Cited by 241
Barr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
on behalf of the NACCP group*, Taal, B. G., Van Tinteren, H., & Zoetmulder, F. A. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2117 · Cited by 218
Wolmark, N., Rockette, H., Wickerham, D. L., Fisher, B., Redmond, C., Fisher, E. R., Potvin, M., Davies, R. J., Jones, J., & Robidoux, A. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1466 · Cited by 211
Multifocal inflammatory leukoencephalopathy with 5‐fluorouracil and levamisole
Hook, C. C., Kimmel, D. W., Kvols, L. K., Scheithauer, B. W., Forsyth, P. A., Rubin, J., Moertel, C. G., & Rodriguez, M. (1992) · Annals of Neurology · doi:10.1002/ana.410310306 · Cited by 153
Graziano, F., & Cascinu, S. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg284 · Cited by 147
McCollum, A. D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1160 · Cited by 146
UYLDEGROOT, C., Vermorken, J. B., HannaJr., M. G., Verboom, P., Groot, M., Bonsel, G. J., Meijer, C. J. L. M., & Pinedo, H. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.015 · Cited by 146
Hanna, M. G., Hoover, H. C., Vermorken, J. B., Harris, J. E., & Pinedo, H. M. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00485-0 · Cited by 141
Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum and the Meta-Analysis Group in Cancer (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.065 · Cited by 135
FIELDING, L. P., Hittinger, R., Grace, R., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91708-g · Cited by 134
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
Kerr, D. J., Dunn, J., Langman, M. J. S., Smith, J. L., Midgley, R. S., Stanley, A., Stokes, J. C., Julier, P., Iveson, C., Duvvuri, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071841 · Cited by 133
Dignam, J. J., Colangelo, L. H., Tian, W., Jones, J. M., Smith, R. E., Wickerham, D. L., & Wolmark, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1933 · Cited by 131
de Gramont, A., Boni, C., Navarro, M., Tabernero, J. M., Hickish, T., Topham, C., Bonetti, A. V., Clingan, P., Lorenzato, C., & André, T. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4007 · Cited by 131
Gray, R. G., Barnwell, J., Hills, R. K., McConkey, C., Williams, N., & Kerr, R. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3501 · Cited by 126
Mitomi, T., Tsuchiya, S., Iijima, N., Aso, K., Suzuki, K., Nishiyama, K., AMANO, T., Takahashi, T., Murayama, N., Oka, H., et al. (1992) · Diseases of the Colon & Rectum · doi:10.1007/bf02050666 · Cited by 123
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., & Laurie, J. A. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.12.2386 · Cited by 123
Portal Vein Chemotherapy for Colorectal Cancer: a Meta-analysis of 4000 Patients in 10 Studies
Liver Infusion Meta-analysis Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.7.497 · Cited by 121
Glimelius, B. L. G., Dahl, O., Cedermark, B., Jakobsen, A. K. M., Bentzen, S. M., Starkhammar, H., Grönberg, H., Hultborn, R., Albertsson, M., Påhlman, L., et al. (2005) · Acta Oncologica · doi:10.1080/02841860500355900 · Cited by 115
Should Dukes' B patients receive adjuvant therapy? A statistical perspective
Buyse, M. E., & Piedbois, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90247-7 · Cited by 109
Beart, R. W. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410190095015 · Cited by 108
Matsumoto, S., Imaeda, Y., Umemoto, S., KOBAYASHI, K. P., Suzuki, H., & Okamoto, T. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600048 · Cited by 107
Glimelius, B. L. G., Dahl, O., Cedermark, B., Jakobsen, A. K. M., Bentzen, S. M., Starkhammar, H., Grönberg, H., Hultborn, R., Albertsson, M., Påhlman, L., et al. (2005) · Acta Oncologica · doi:10.1080/02841860500355900a · Cited by 95
Current Issues in Adjuvant Treatment of Stage II Colon Cancer
André, T., Sargent, D. J., Tabernero, J. M., O’Connell, M. J., Buyse, M. E., Sobrero, A. F., Misset, J. L., Boni, C., & de Gramont, A. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.07.003 · Cited by 94
Adjuvant chemotherapy in colorectal carcinoma
Dubé, S., Heyen, F., & Jenicek, M. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02055679 · Cited by 91
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial
Rougier, P. R., Sahmoud, T., Nitti, D., Curran, D., Doci, R., Waele, B. D., Nakajima, T., Rauschecker, H., Labianca, R., Pector, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08169-5 · Cited by 84
Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01
Smith, R. E., Colangelo, L. H., Wieand, H. S., Begovič, M., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh220 · Cited by 77
Kato, T., Ohashi, Y., Nakazato, H., Koike, A., Saji, S., Suzuki, H., Takagi, H., Nimura, Y., Hasumi, A., Baba, S., et al. (2002) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-002-0278-x · Cited by 71
Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer
Marsoni, S. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90246-5 · Cited by 67
Wiesenfeld, M., O'Connell, M. J., Wieand, H. S., Gonchoroff, N. J., Donohue, J. H., Fitzgibbons, R. J., Krook, J. E., Mailliard, J. A., Gerstner, J. B., & Pazdur, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2324 · Cited by 64
Hartung, G., Hofheinz, R. D., Dencausse, Y., et al. (2005) · Oncology Research and Treatment · doi:10.1159/000084595 · Cited by 64
Sakamoto, J., Hamada, C., Kodaira, S., Nakazato, H., & Ohashi, Y. (1999) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/29.2.78 · Cited by 63
Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions
Monga, D. K., & O’Connell, M. J. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.08.015 · Cited by 60
Nichols, P., Ramsden, C. W., Ward, U., Sedman, P. C., & Primrose, J. M. (1992) · PubMed · Cited by 53
Cimetidine as an adjuvant treatment in colorectal cancer
Svendsen, L. B., Ross, C., Knigge, U., Frederiksen, H. J., Graversen, P. L., Kjærgåfrd, J., Luke, M., Stimpel, H., & Sparsø, B. H. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02148852 · Cited by 51
Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer?
Sobrero, A. F., & Köhne, C.-H. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70727-6 · Cited by 47
Survival of Patients With Stage B2 Colon Carcinoma
Nauta, R. J. (1989) · Archives of Surgery · doi:10.1001/archsurg.1989.01410020050008 · Cited by 46
Kelly, M. D., King, J., Cherian, M., Dwerryhouse, S. J., Finlay, I. G., Adams, W. J., King, D. W., Lubowski, D. Z., & Morris, D. L. (1999) · Cancer · Cited by 44
Sadahiro, S., Suzuki, T., Ishikawa, K., Yasuda, S., Tajima, T., Makuuchi, H., Saitoh, T., & Murayama, C. (2004) · Cancer · doi:10.1002/cncr.11945 · Cited by 42
Nitti, D., Wils, J. A., Sahmoud, T., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00052-x · Cited by 41
Sakamoto, J., Hamada, C., Rahman, M., Kodaira, S., Ito, K., Nakazato, H., Ohashi, Y., & Yasutomi, M. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi147 · Cited by 37
Nio, Y., Tsubono, M., Tseng, C., Morimoto, H., Kawabata, K., Masai, Y., Shiraishi, T., Imai, S., Ohgaki, K., & Tobe, T. (1992) · Biotherapy · doi:10.1007/bf02171756 · Cited by 34
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
Midgley, R. S., & Kerr, R. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0228 · Cited by 33
Lacour, J., Laplanche, A., Malafosse, M., Gallot, D., Julien, M., Rotman, N., Guivarc'h, M., Jc, R.-A., Lasser, P., & Hautefeuille, P. (1992) · PubMed · Cited by 33
Gray, B. N., Walker, C., Andrewartha, L., et al. (1989) · Journal of Surgical Oncology · doi:10.1002/jso.2930400109 · Cited by 29
Peri-operative modulation of cellular immunity in patients with colorectal cancer
Nichols, P., Ramsden, C. W., Ward, U., Trejdosiewicz, L. K., Ambrose, N. S., & Primrose, J. M. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05968.x · Cited by 29
Sargent, D. J., Wieand, S., Benedetti, J., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., Francini, G., de Gramont, A., & Goldberg, R. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.3502 · Cited by 27
Figueredo, A. T., Fawcet, S. E., Molloy, D. W., Dobranowski, J., & Paulseth, J. E. (1995) · Cancer Investigation · doi:10.3109/07357909509024930 · Cited by 26
Self-citationBrivio, F., Fumagalli, L. A. M., Lissoni, P., Nardone, A., Nespoli, L. C., Fattori, L., Denova, M., Chiarelli, M. E., & Nespoli, A. (2006) · PubMed · Cited by 23
A Trial of Adjuvant Therapy in Colorectal Cancer: The VICTOR Trial
Pendlebury, S., Duchesne, F., Reed, K. A., Smith, J. L., & Kerr, D. J. (2003) · Clinical Colorectal Cancer · doi:10.3816/ccc.2003.n.013 · Cited by 18
Adjuvant Therapy of Colorectal Cancer: Why We Still Don't Know
Buyse, M. (1988) · JAMA · doi:10.1001/jama.1988.03720240033031 · Cited by 18
Recent meta-analyses in colorectal cancer
Piedbois, P., & Buyse, M. E. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00014 · Cited by 5
Cited by
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Tie, J., Cohen, J. D., Lahouel, K., Lo, S. N., Wang, Y., Kosmider, S., Wong, R., Shapiro, J., Lee, M., Harris, S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200075 · Cited by 1,091
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Smith, J. J., Deane, N. G., Wu, F., Merchant, N. B., Zhang, B., Jiang, A., Lu, P., Johnson, J. C., Schmidt, C., Bailey, C. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.005 · Cited by 716
Papamichael, D., Audisio, R. A., Glimelius, B., de Gramont, A., Glynne-Jones, R., Haller, D., Köhne, C.-H., Rostoft, S., Lemmens, V., Mitry, E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu253 · Cited by 471
Jorissen, R. N., Gibbs, P., Christie, M., Prakash, S., Lipton, L., Desai, J., Kerr, D., Aaltonen, L. A., Arango, D., Kruhøffer, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1431 · Cited by 437
Metadata
- Authors
- Figueredo, A., Coombes, M. E., & Mukherjee, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2008-07-16
- Volume
- 2010
- Issue
- 1
- Pages
- CD005390-CD005390
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1839179899
- Cited by
- 266
- References
- 90
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.